Global Biopsy Devices Market was valued at USD 2.38 Billion in 2023 and is expected to reach USD 4.29 Billion by 2030, Growing at a CAGR of 7.4% from 2023 to 2030.

The Biopsy Devices Market is a rapidly growing sector in the medical industry, with a wide range of products available for various types of biopsy procedures. Biopsy devices are used to obtain samples of tissue from the body for diagnostic testing, and they come in different forms, including needle-based devices, imaging-guided biopsy devices, and tissue biopsy forceps.

There are several factors driving the growth of the biopsy devices market. One of the key factors is the increasing prevalence of chronic diseases such as cancer, which requires accurate diagnosis and treatment. The growing demand for minimally invasive procedures and the increasing adoption of advanced technologies in biopsy procedures are also contributing to the growth of the market.

Overall, the Biopsy Devices Market is expected to experience strong growth in the coming years due to the increasing demand for accurate diagnosis and treatment of diseases and the adoption of advanced technologies in biopsy procedures.

The COVID-19 pandemic has had a significant impact on the biopsy devices market, as the demand for biopsy procedures has increased due to the high number of COVID-19 cases worldwide. The pandemic has also led to a shortage of personal protective equipment (PPE) and other medical supplies, including biopsy devices, which has affected the supply chain of the biopsy devices market.

However, the pandemic has also led to the adoption of telemedicine and remote monitoring, which has helped to reduce the burden on healthcare systems and has allowed for the continuation of medical procedures, including biopsy procedures, remotely.

Global Biopsy Devices Market Segmentation

The Biopsy Guidance Systems Product Segment is expected to hold a significant share of the global biopsy devices market, due to the increasing adoption of advanced technologies such as ultrasound and MRI guidance in biopsy procedures.

By Product

• Biopsy Guidance Systems
• Needle Based Biopsy Guns
• Biopsy Needles
• Biopsy Forceps
• Others

By Application

• Breast Biopsy
• Lung Biopsy
• Colorectal Biopsy
• Prostate Biopsy
• Others

Guidance Technique

• Ultrasound Guided Biopsy
• Stereotactic Guided Biopsy
• MRI Guided Biopsy
• Others

End-User

• Hospitals and Clinics
• Academic and Research Institutes
• Others

Key Companies & Market Share Insights

• Becton, Dickinson and Company
• Hologic Inc.
• Danaher Corporation
• Cook Medical
• Boston Scientific Corporation
• Intact Medical Corporation
• Gallini Medical
• TSK Laboratory Europe BV
• Argon Medical Devices
• B. Braun Melsungen AG
• Cardinal Health Inc.
• Medtronic PLC
• Fujifilm Holdings Corporation
• INRAD Inc.
• Olympus Corporation

Recent Developments in the Biopsy Devices Market

The launch of new and innovative biopsy devices: 

There have been a number of new biopsy devices launched in recent years, including needle-based biopsy guns with enhanced accuracy and precision, imaging-guided biopsy devices with advanced imaging capabilities, and tissue biopsy forceps with improved grip and control. These new devices are expected to drive market growth by offering improved diagnostic accuracy and patient comfort.

The adoption of advanced technologies: 

The biopsy devices market is experiencing the adoption of advanced technologies such as robotics, artificial intelligence, and 3D printing. These technologies are helping to improve the accuracy and efficiency of biopsy procedures, as well as reducing the risk of errors and complications.

The increasing focus on research and development: 

There is a growing focus on research and development in the biopsy devices market, with companies investing in the development of new and innovative products. This is expected to lead to the introduction of new biopsy devices with improved performance and capabilities, driving market growth.

The growing demand for minimally invasive procedures: 

The demand for minimally invasive biopsy procedures is increasing due to the benefits they offer in terms of patient comfort and recovery time. This is expected to drive the demand for biopsy devices that are suitable for minimally invasive procedures.

Overall, these recent developments are expected to drive the growth of the biopsy devices market in the coming years.

Segmentation insights

Application

The Breast Biopsy segment is expected to hold a dominant share of the global biopsy devices market due to the high incidence of breast cancer and the increasing awareness about the importance of early diagnosis and treatment.

Guidance Technique

The ultrasound-guided biopsy segment is expected to hold a significant share of the global biopsy devices market due to the wide availability and affordability of ultrasound technology.

End-user

The hospitals and clinics segment are expected to hold a dominant share of the global biopsy devices market due to the high volume of biopsy procedures performed in these settings.

Some Frequently Asked Questions (FAQ) about trends in the Biopsy Devices Market

What are the current trends in the biopsy devices market?

Some current trends in the biopsy devices market include an increasing focus on minimally invasive biopsy procedures, the development of more advanced biopsy guidance systems, and the use of 3D printing technology in the development of biopsy devices.

What is driving the growth of the Biopsy Devices Market?

Several factors are driving the growth of the biopsy devices market, including an aging population, an increasing prevalence of chronic diseases, and advances in technology that have made biopsy procedures more accurate and less invasive.

What are the challenges facing the Biopsy Devices Market?

Some challenges facing the biopsy devices market include regulatory barriers, high costs associated with developing and marketing biopsy devices, and the need for ongoing training and education for healthcare professionals who use biopsy devices.

What is the future outlook for the Biopsy Devices Market?

The biopsy devices market is expected to continue growing in the coming years, driven by factors such as an aging population, an increasing prevalence of chronic diseases, and advances in technology. However, the market may also face challenges such as regulatory barriers and the need for ongoing training and education for healthcare professionals.

Regional Insights

North America is expected to dominate the biopsy devices market due to the presence of a large number of biopsy device manufacturers, the availability of advanced healthcare infrastructure, and the high adoption of biopsy devices in the region. Europe and Asia-Pacific are also expected to witness significant growth in the biopsy devices market due to the increasing awareness about the benefits of early diagnosis and treatment of diseases and the rising healthcare expenditure in these regions.

North America

• U.S.
• Canada

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Switzerland
• Belgium
• Rest of Europe

Asia-Pacific

• South Korea
• Japan
• China
• India
• Australia
• Philippines
• Singapore
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Colombia
• Brazil
• Argentina
• Peru
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA